Image - 14 December 2021

Image 1.jpg

License:: Media Use
The content may be downloaded by journalists, bloggers, columnists, creators of public opinion, etc. It can be used and shared in different media channels to convey, narrate, and comment on your press releases, posts, or information, provided that the content is unmodified. The author or creator shall be attributed to the extent and in the manner required by good practice (this means, for example, that photographers should be attributed).
File format:: .jpg
Size:: 720 x 350, 241 KB

Download

Topics

Contacts

Felicity Hudson

Press contact Head of Reputation Management Discovery Group media_relations_team@discovery.co.za 0115294514

Nthabiseng Chapeshamano

Press contact Senior Reputation Manager Discovery Group Sustainability, Discovery Green and Discovery Insure nthabisengc@discovery.co.za

Zeenat Moorad

Press contact Senior Reputation Manager Banking | Vitality | Sponsorships zeenatm2@discovery.co.za

Karishma Jivan

Press contact Senior Reputation Management Consultant Healthcare & Sustainability karishmaj2@discovery.co.za

Lianne Osterberger

Press contact Senior Manager: Media Relations and Reputation Management LianneO@discovery.co.za 083 27 27 313

Hannah Newbold

Press contact Reputation Management Consultant Insure & Invest hannahn@discovery.co.za

Discovery Health, South Africa’s largest private health insurance administrator, releases at-scale, real-world analysis of Omicron outbreak based on 211 000 COVID-19 test results in South Africa, including collaboration with the South Africa

Johannesburg, 14 December 2021
Summary:
Vaccine effectiveness: o The two-dose Pfizer-BioNTech vaccination provides 70% protection against severe complications of COVID-19 requiring hospitalisation, and 33% protection against COVID-19 infection, during the current Omicron wave. Reinfection risk: For individuals who have had COVID-19 previously, the risk of reinfection with Omicron is